Tech Company Financing Transactions
Epic Sciences Funding Round
Epic Sciences closed a $52 million Series E funding round on 9/13/2018. Investors included Blue Ox Healthcare Partners and private investors.
Transaction Overview
Company Name
Announced On
9/13/2018
Transaction Type
Venture Equity
Amount
$52,000,000
Round
Series E
Investors
Blue Ox Healthcare Partners (Lead Investor) (Charles Kennedy)
Proceeds Purpose
Proceeds from the fundraising round are expected be used to accelerate Epic's clinical studies for oncology decision support services in its pipeline and execution of its long-term growth plan.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9381 Judicial Dr. 200
La Jolla, CA 92121
USA
La Jolla, CA 92121
USA
Phone
Website
Email Address
Overview
Developing new diagnostic blood tests that can identify and characterize circulating tumor cells to improve cancer detection and to personalize medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Lloyd Sanders
Chief Financial Officer
Joel Smith
Chief Medical Officer
Richard Wenstrup
Chief Technical Officer
Chockalingam Palaniappan
Browse more venture capital transactions:
Prev: 9/13/2018: Sysdig venture capital transaction
Next: 9/13/2018: Finhaven venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs